Search Videos and More
News
Baptist Health and Florida International University to begin exclusive negotiations on comprehensive alliance
Baptist Health and Florida International University, through its Herbert Wertheim College of Medicine, today announced they have entered into exclusive negotiations to develop a comprehensive alliance, which will drive clinical, research and education advancements for the benefit of the South Florida community.
Podcast
HPV-Related Cancers
Join Miami Cancer Institute experts John P. Diaz M.D., chief of gynecologic oncology, and Alessandro Villa D.D.S., Ph.D., M.P.H., chief of oral medicine, oral oncology and dentistry, as they discuss HPV-related cancers, preventative screenings, the HPV vaccine, and oral complications sometimes caused by cancer-related treatment.
News
Jean-Marie Stephan, M.D., joins Miami Cancer Institute as Gynecological Surgical Oncologist
Board-certified gynecological surgical oncologist Jean-Marie Stephan, M.D., recently joined Baptist Health Miami Cancer Institute.
News
Radiopharmaceutical PET Agent Helps Physicians Identify Recurrent Brain Metastases
The results of a multi-institutional clinical trial led by Miami Cancer Institute, a part of Baptist Health, could bring a monumental shift in the management of patients with brain metastases. Rupesh Kotecha, M.D., chief of Radiosurgery and director of Central Nervous System Metastasis at the Institute, presented the findings at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 2.
News
HER2-Positive Breast Cancer Research: Some Women Can Bypass Radiation
A new study led by Baptist Health Miami Cancer Institute and Lynn Cancer Institute researchers is showing that more women with breast cancer may be able to avoid the toxicities of radiation therapy after mastectomy.
News
Miami Cancer Institute to Present Latest Cancer Research at 2023 ASCO Annual Meeting
Miami Cancer Institute, part of Baptist Health South Florida, today announced its oral and poster presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, at McCormick Place in Chicago, Illinois.
News
Cracking Glioblastoma’s Deadly Code: Research Focused on Improving Diagnosis and Genomics to Revolutionize Care
Even with growing awareness of the devastating effects of glioblastoma, the most common and aggressive form of brain cancer, treatment options remain limited and patients typically survive just 15-18 months beyond diagnosis. Researchers at the Miami Cancer Institute and Miami Neuroscience Institute, part of Baptist Health South Florida, are focusing their efforts to advance understanding of the disease and improve diagnostic, prognostic, and therapeutic outcomes.
Video
Baptist Health’s High-Tech High-Touch Approach - Live Webcast on Breast Health
Originally Broadcast: Wednesday, May 31, 2023 | 5:30-6:30pm ET Join Baptist Health experts for a webinar focused on breast health; beginning with imaging through the continuum of care at Miami Cancer Institute.
News
Lutetium-177 (177Lu) - PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Updated National Society Guidelines
The most recent American Society of Clinical Oncology (ASCO) guidelines for the management of metastatic castration-resistant prostate cancer (mCRPC) was published in 2014.
News
AI: A Game-Changer in Screening Mammography
Diagnostic radiologists can scroll through upwards of 25,000 mammography images per day in search of the smallest suspicious lesion. The task is extremely taxing and image interpretation is variable.
News
Milestone 1000th Patient Treated Using Gamma Knife at Miami Cancer Institute
Leading the fight against brain metastases, Baptist Health Miami Cancer Institute hit a new milestone recently. The center treated its 1000th patient using Gamma Knife radiosurgery, an incisionless radiation therapy that precisely targets a tumor, importantly minimizing damage to otherwise healthy brain tissue.
News
New Class of Drugs Show Promise in Treating Recurrent Cervical Cancer
With a poor prognosis for many patients with relapsing gynecological cancers ? particularly for those who received conventional treatment only ? gynecological oncologists are on the search for novel therapies.